HC Wainwright reaffirmed their buy rating on shares of TransCode Therapeutics (NASDAQ:RNAZ – Free Report) in a report issued on Wednesday morning, Benzinga reports. HC Wainwright currently has a $3.00 target price on the stock. TransCode Therapeutics Stock Performance TransCode Therapeutics stock opened at $1.78 on Wednesday. TransCode Therapeutics has a 52-week low of $0.42 […]
HC Wainwright reiterated their buy rating on shares of TransCode Therapeutics (NASDAQ:RNAZ – Free Report) in a report released on Wednesday morning, Benzinga reports. The brokerage currently has a $3.00 target price on the stock. TransCode Therapeutics Stock Performance NASDAQ:RNAZ opened at $1.78 on Wednesday. The firm has a market cap of $11.75 million, a […]
BOSTON, May 29, 2024 (GLOBE NEWSWIRE) TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced new preliminary data
TransCode Therapeutics Reports Positive Data from First-in-Human Clinical Study Using Novel Lead Therapeutic Candidate, TTX-MC138 tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.